MedTrace Logo

Nalbuphine and Flurbiprofen for Oculoplastic Surgery

NCT03422887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2021-02-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the postoperative pain and discomfort using flurbiprofen axetil or nalbuphine administration after oculoplastic surgery under general anesthesia.

Conditions

  • Surgery
  • Anesthesia
  • Pain

Interventions

DRUG

Nalbuphine

Nalbuphine administration during surgery

DRUG

Flurbiprofen Axetil

Flurbiprofen axetil administration during surgery

DRUG

Nalbuphine and Flurbiprofen Axetil

Nalbuphine and Flurbiprofen Axetil administration during surgery

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Huijing Ye · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2018-08-31
Completion
2018-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03422887 on ClinicalTrials.gov